Article
Diversity in blueberry genotypes and developmental stages enables discrepancy in the bioactive compounds, metabolites, and cytotoxicity.
Food chemistry - 16 Apr 2022
Das Protiva Rani, Darwish Ahmed G, Ismail Ahmed, Haikal Amr M, Gajjar Pranavkumar, Balasubramani Subramani Paranthaman, Sheikh Mehboob B, Tsolova Violeta, Soliman Karam F A, Sherif Sherif M, El-Sharkawy Islam
Abstract excerpt
Eight blueberry cultivars at three developmental stages were investigated for metabolite profiling, antioxidant, and anticancer activities. Cultivars- and developmental stages-variations were determined in total phenolic, flavonoid, DPPH, and FRAP antioxidant assays. The anticancer capacity was equal against A549, HepG2, and Caco-2 cancer cells, whereas the inhibition rate was dose-, incubation period-,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
